Andrew Edward Left is an activist short seller, author and editor of the online investment newsletter Citron Research, formerly StockLemon.com. Left is known for advising investors on short selling and has often appeared on various media outlets such as CNBC and Bloomberg to talk about his opinions on stocks. In 2016, Left was banned for five years by the Hong Kong Market Misconduct Tribunal for disclosing false or misleading information, and so inducing transactions under the Securities and Futures Ordinance.
Comment: Watch LEFT and his $5 target on stock its $44. Like i said he put out his BullShit report the people panic and sell and he makes a quick profit you know they are not short anymore. FOLLOW HIS SELL TICKETS in PTON I bet you will see the Sells and 10 minutes after the attack and report is out THEY COVER
Global Newswire, 27 April 2020
BOSTON, April 27, 2020 (GLOBE NEWSWIRE) — Today, research analyst Citron Research published a report calling Inovio (INO) “The COVID-19 Version of Theranos,” in which Citron slashed its target price for Inovio common stock by 93%.
Dr Left has a $1 target stock is $11 ( you know he shorted at $16-17 and covered already never waiting for his $1 target SHORT AND DISTORT for a quick profit
MarketInsider, 10 December 2019
- Citron Research, run by the famed short-seller Andrew Left, slapped Peloton with a $5 price target on Tuesday.
- That would imply an 86% drop from Monday’s close of $34.77.
- Citron argued that the losses would come amid “intense” competition that’s mounting.
- Shares of Peloton fell as much as 9.1% on Tuesday.
Comment: Yelling fire in a crowded theatre is a crime A short and distort SELL REPORT How about selling his sell tickets IS he still short? his target is $5 right I bet he covered 10 min after his report . Andrew Left should be under investigation. His recommendations should be compared to his positions.
MarketWatch, 29 May 2019
Citron Research’s Andrew Left, a noted short seller, is once again slamming Jumia Technologies AG as a “fraud,” this time in a video that includes footage of what he says are former employees who accuse the company of placing fake orders.
Comment: Down from $36 to $3 based on a naked short selling campaign apparently led by Andrew Left.
Proactive Investors, 4 April 2019
Citron’s short position stems from a ‘perfect storm’ of business setbacks that will knock Shopify ‘off its high wire to $100 in the next 12 months’
Shares of Shopify Inc (NYSE:SHOP) tumbled Thursday after famed short-seller Andrew Left of Citron Research went bearish and urged investors to short the Canadian e-commerce company.
In a research note, Left and his team make the case that their newly-adopted short position stems from a “perfect storm” of business setbacks that will knock Shopify “off its high wire to $100 in the next 12 months.”
Reuters, 26 February 2019
HONG KONG (Reuters) – U.S. short seller Andrew Left lost his legal bid on Tuesday to overturn a five-year ban from Hong Kong’s financial markets and a fine for market manipulation.
Left, founder of U.S.-based short-seller Citron Research, was banned in 2016 after he was found culpable of market misconduct in connection with the publication of a research report on Chinese property developer China Evergrande Group.
Business Insider, 30 August 2018
Citron Research — a short-selling firm with a history of wiping out stock prices and run by Andrew Left — has a new target: cannabis stocks.
In a report published Thursday, the firm says Cronos, one of the most valuable publicly traded marijuana companies, is worth roughly one-third of its current price: $3.50 per share.
Berkeley Lovelace Jr.
CNBC, 15 May 2017
Exact Sciences Chairman and CEO Kevin Conroy fired back at a bearish assessment made by Citron Research’s Andrew Left, who predicted a long-term drop in the cancer testing company’s stock to a near-zero single digit.
Citron said in a report on Monday that Exact Sciences’ Cologuard cancer test, an at home screening for colon cancer, is “inferior” and shouldn’t be pitching it as an alternative to a colonoscopy.
Comment: Andrew Left’s Citron appears to be a front for naked short sellers.